22 May 2013
Keywords: Seattle Genetics, GlaxoSmithKline, ADC technoilogy, chemotherapy, Licensing, Monoclonal antibodies
Article | 22 December 2009
US biotechnology firm Seattle Genetics has secured an initial $12 million from UK drug giant GlaxoSmithKline under which GSK will acquire ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.